Lam Research (NASDAQ:LRCX) Price Target Raised to $155.00

Lam Research (NASDAQ:LRCXFree Report) had its target price raised by Cantor Fitzgerald from $120.00 to $155.00 in a research report released on Wednesday morning,MarketScreener reports. The firm currently has an overweight rating on the semiconductor company’s stock.

Other equities research analysts have also issued research reports about the stock. Oppenheimer upped their target price on shares of Lam Research from $110.00 to $120.00 and gave the stock an “outperform” rating in a report on Thursday, July 31st. Erste Group Bank assumed coverage on shares of Lam Research in a report on Thursday, August 14th. They issued a “buy” rating on the stock. Needham & Company LLC upped their target price on shares of Lam Research from $110.00 to $115.00 and gave the stock a “buy” rating in a report on Thursday, July 31st. Mizuho upped their target price on shares of Lam Research from $120.00 to $130.00 and gave the stock an “outperform” rating in a report on Friday, September 12th. Finally, HSBC set a $127.00 target price on shares of Lam Research and gave the stock a “hold” rating in a report on Tuesday. Twenty-three analysts have rated the stock with a Buy rating and eight have assigned a Hold rating to the stock. Based on data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and a consensus target price of $119.20.

View Our Latest Report on Lam Research

Lam Research Price Performance

Shares of NASDAQ LRCX opened at $145.81 on Wednesday. The firm’s 50-day moving average price is $110.47 and its 200-day moving average price is $92.27. Lam Research has a 1-year low of $56.32 and a 1-year high of $147.91. The firm has a market capitalization of $183.87 billion, a P/E ratio of 35.05, a P/E/G ratio of 1.79 and a beta of 1.84. The company has a current ratio of 2.21, a quick ratio of 1.55 and a debt-to-equity ratio of 0.38.

Lam Research (NASDAQ:LRCXGet Free Report) last announced its quarterly earnings data on Wednesday, July 30th. The semiconductor company reported $1.33 earnings per share for the quarter, beating the consensus estimate of $1.21 by $0.12. Lam Research had a net margin of 29.07% and a return on equity of 58.17%. The firm had revenue of $5.17 billion for the quarter, compared to analyst estimates of $4.99 billion. During the same quarter in the prior year, the business earned $1.03 earnings per share. The business’s quarterly revenue was up 33.6% compared to the same quarter last year. Lam Research has set its Q1 2026 guidance at 1.100-1.300 EPS. Equities research analysts anticipate that Lam Research will post 3.71 earnings per share for the current fiscal year.

Lam Research Increases Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Wednesday, October 15th. Shareholders of record on Wednesday, September 24th will be paid a $0.26 dividend. This is a positive change from Lam Research’s previous quarterly dividend of $0.23. The ex-dividend date is Wednesday, September 24th. This represents a $1.04 annualized dividend and a yield of 0.7%. Lam Research’s dividend payout ratio (DPR) is 25.00%.

Institutional Investors Weigh In On Lam Research

Several institutional investors and hedge funds have recently added to or reduced their stakes in the company. Norges Bank bought a new position in shares of Lam Research during the 2nd quarter valued at approximately $1,894,585,000. Vanguard Group Inc. grew its position in shares of Lam Research by 6.9% during the 1st quarter. Vanguard Group Inc. now owns 129,152,102 shares of the semiconductor company’s stock valued at $9,389,358,000 after acquiring an additional 8,364,375 shares during the period. Nuveen LLC bought a new position in shares of Lam Research during the 1st quarter valued at approximately $604,344,000. JPMorgan Chase & Co. grew its position in shares of Lam Research by 14.4% during the 2nd quarter. JPMorgan Chase & Co. now owns 40,622,437 shares of the semiconductor company’s stock valued at $3,954,188,000 after acquiring an additional 5,102,589 shares during the period. Finally, Price T Rowe Associates Inc. MD grew its position in shares of Lam Research by 99.7% during the 1st quarter. Price T Rowe Associates Inc. MD now owns 5,739,221 shares of the semiconductor company’s stock valued at $417,242,000 after acquiring an additional 2,864,863 shares during the period. Hedge funds and other institutional investors own 84.61% of the company’s stock.

About Lam Research

(Get Free Report)

Lam Research Corporation designs, manufactures, markets, refurbishes, and services semiconductor processing equipment used in the fabrication of integrated circuits. The company offers ALTUS systems to deposit conformal films for tungsten metallization applications; SABRE electrochemical deposition products for copper interconnect transition that offers copper damascene manufacturing; SOLA ultraviolet thermal processing products for film treatments; and VECTOR plasma-enhanced CVD ALD products.

Featured Stories

Analyst Recommendations for Lam Research (NASDAQ:LRCX)

Receive News & Ratings for Lam Research Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Lam Research and related companies with MarketBeat.com's FREE daily email newsletter.